Find an abstract and a link to most of the publications produced by Nordic Bioscience
IMPORTANCE: Additional therapies are needed for prevention of osteoporotic fractures. Abaloparatide is a selective activator of the parathyroid hormone type 1 receptor. OBJECTIVE: To determine the efficacy and safety of abaloparatide, 80 μg, vs placebo for prevention of new vertebral fracture in po...
August 16, 2016
Journal:
JAMA.
Author:
Miller PD, Hattersley G, Riis BJ, Williams GC, Russo LA, Alexandersen P, Zerbini CA, Hu MY, Harris AG, Fitzpatrick LA, Cosman F, Christiansen C, Lau EM
Search and find publications that we have published.
Please don't hesitate to contact us if you have any questions or other inquiries.